                         SEQUENCE LISTING

<110>  Sanatio BioScience Corp.
 
<120>  Modular Therapeutics Having Anti-RNA Activity and Methods Thereof

<130>  177264.003WO1

<150>  US 63/020,398
<151>  2020-05-05

<150>  US 63/020,796
<151>  2020-05-06

<150>  US 63/022,764
<151>  2020-05-11

<160>  119   

<170>  PatentIn version 3.5

<210>  1
<211>  3821
<212>  DNA
<213>  SARS-CoV-2

<400>  1
tgtttgtttt tcttgtttta ttgccactag tctctagtca gtgtgttaat cttacaacca       60

gaactcaatt accccctgca tacactaatt ctttcacacg tggtgtttat taccctgaca      120

aagttttcag atcctcagtt ttacattcaa ctcaggactt gttcttacct ttcttttcca      180

atgttacttg gttccatgct atacatgtct ctgggaccaa tggtactaag aggtttgata      240

accctgtcct accatttaat gatggtgttt attttgcttc cactgagaag tctaacataa      300

taagaggctg gatttttggt actactttag attcgaagac ccagtcccta cttattgtta      360

ataacgctac taatgttgtt attaaagtct gtgaatttca attttgtaat gatccatttt      420

tgggtgttta ttaccacaaa aacaacaaaa gttggatgga aagtgagttc agagtttatt      480

ctagtgcgaa taattgcact tttgaatatg tctctcagcc ttttcttatg gaccttgaag      540

gaaaacaggg taatttcaaa aatcttaggg aatttgtgtt taagaatatt gatggttatt      600

ttaaaatata ttctaagcac acgcctatta atttagtgcg tgatctccct cagggttttt      660

cggctttaga accattggta gatttgccaa taggtattaa catcactagg tttcaaactt      720

tacttgcttt acatagaagt tatttgactc ctggtgattc ttcttcaggt tggacagctg      780

gtgctgcagc ttattatgtg ggttatcttc aacctaggac ttttctatta aaatataatg      840

aaaatggaac cattacagat gctgtagact gtgcacttga ccctctctca gaaacaaagt      900

gtacgttgaa atccttcact gtagaaaaag gaatctatca aacttctaac tttagagtcc      960

aaccaacaga atctattgtt agatttccta atattacaaa cttgtgccct tttggtgaag     1020

tttttaacgc caccagattt gcatctgttt atgcttggaa caggaagaga atcagcaact     1080

gtgttgctga ttattctgtc ctatataatt ccgcatcatt ttccactttt aagtgttatg     1140

gagtgtctcc tactaaatta aatgatctct gctttactaa tgtctatgca gattcatttg     1200

taattagagg tgatgaagtc agacaaatcg ctccagggca aactggaaag attgctgatt     1260

ataattataa attaccagat gattttacag gctgcgttat agcttggaat tctaacaatc     1320

ttgattctaa ggttggtggt aattataatt acctgtatag attgtttagg aagtctaatc     1380

tcaaaccttt tgagagagat atttcaactg aaatctatca ggccggtagc acaccttgta     1440

atggtgttga aggttttaat tgttactttc ctttacaatc atatggtttc caacccacta     1500

atggtgttgg ttaccaacca tacagagtag tagtactttc ttttgaactt ctacatgcac     1560

cagcaactgt ttgtggacct aaaaagtcta ctaatttggt taaaaacaaa tgtgtcaatt     1620

tcaacttcaa tggtttaaca ggcacaggtg ttcttactga gtctaacaaa aagtttctgc     1680

ctttccaaca atttggcaga gacattgctg acactactga tgctgtccgt gatccacaga     1740

cacttgagat tcttgacatt acaccatgtt cttttggtgg tgtcagtgtt ataacaccag     1800

gaacaaatac ttctaaccag gttgctgttc tttatcagga tgttaactgc acagaagtcc     1860

ctgttgctat tcatgcagat caacttactc ctacttggcg tgtttattct acaggttcta     1920

atgtttttca aacacgtgca ggctgtttaa taggggctga acatgtcaac aactcatatg     1980

agtgtgacat acccattggt gcaggtatat gcgctagtta tcagactcag actaattctc     2040

ctcggcgggc acgtagtgta gctagtcaat ccatcattgc ctacactatg tcacttggtg     2100

cagaaaattc agttgcttac tctaataact ctattgccat acccacaaat tttactatta     2160

gtgttaccac agaaattcta ccagtgtcta tgaccaagac atcagtagat tgtacaatgt     2220

acatttgtgg tgattcaact gaatgcagca atcttttgtt gcaatatggc agtttttgta     2280

cacaattaaa ccgtgcttta actggaatag ctgttgaaca agacaaaaac acccaagaag     2340

tttttgcaca agtcaaacaa atttacaaaa caccaccaat taaagatttt ggtggtttta     2400

atttttcaca aatattacca gatccatcaa aaccaagcaa gaggtcattt attgaagatc     2460

tacttttcaa caaagtgaca cttgcagatg ctggcttcat caaacaatat ggtgattgcc     2520

ttggtgatat tgctgctaga gacctcattt gtgcacaaaa gtttaacggc cttactgttt     2580

tgccaccttt gctcacagat gaaatgattg ctcaatacac ttctgcactg ttagcgggta     2640

caatcacttc tggttggacc tttggtgcag gtgctgcatt acaaatacca tttgctatgc     2700

aaatggctta taggtttaat ggtattggag ttacacagaa tgttctctat gagaaccaaa     2760

aattgattgc caaccaattt aatagtgcta ttggcaaaat tcaagactca ctttcttcca     2820

cagcaagtgc acttggaaaa cttcaagatg tggtcaacca aaatgcacaa gctttaaaca     2880

cgcttgttaa acaacttagc tccaattttg gtgcaatttc aagtgtttta aatgatatcc     2940

tttcacgtct tgacaaagtt gaggctgaag tgcaaattga taggttgatc acaggcagac     3000

ttcaaagttt gcagacatat gtgactcaac aattaattag agctgcagaa atcagagctt     3060

ctgctaatct tgctgctact aaaatgtcag agtgtgtact tggacaatca aaaagagttg     3120

atttttgtgg aaagggctat catcttatgt ccttccctca gtcagcacct catggtgtag     3180

tcttcttgca tgtgacttat gtccctgcac aagaaaagaa cttcacaact gctcctgcca     3240

tttgtcatga tggaaaagca cactttcctc gtgaaggtgt ctttgtttca aatggcacac     3300

actggtttgt aacacaaagg aatttttatg aaccacaaat cattactaca gacaacacat     3360

ttgtgtctgg taactgtgat gttgtaatag gaattgtcaa caacacagtt tatgatcctt     3420

tgcaacctga attagactca ttcaaggagg agttagataa atattttaag aatcatacat     3480

caccagatgt tgatttaggt gacatctctg gcattaatgc ttcagttgta aacattcaaa     3540

aagaaattga ccgcctcaat gaggttgcca agaatttaaa tgaatctctc atcgatctcc     3600

aagaacttgg aaagtatgag cagtatataa aatggccatg gtacatttgg ctaggtttta     3660

tagctggctt gattgccata gtaatggtga caattatgct ttgctgtatg accagttgct     3720

gtagttgtct caagggctgt tgttcttgtg gatcctgctg caaatttgat gaagacgact     3780

ctgagccagt gctcaaagga gtcaaattac attacacata a                         3821


<210>  2
<211>  13202
<212>  DNA
<213>  SARS-CoV-2

<400>  2
tggagagcct tgtccctggt ttcaacgaga aaacacacgt ccaactcagt ttgcctgttt       60

tacaggttcg cgacgtgctc gtacgtggct ttggagactc cgtggaggag gtcttatcag      120

aggcacgtca acatcttaaa gatggcactt gtggcttagt agaagttgaa aaaggcgttt      180

tgcctcaact tgaacagccc tatgtgttca tcaaacgttc ggatgctcga actgcacctc      240

atggtcatgt tatggttgag ctggtagcag aactcgaagg cattcagtac ggtcgtagtg      300

gtgagacact tggtgtcctt gtccctcatg tgggcgaaat accagtggct taccgcaagg      360

ttcttcttcg taagaacggt aataaaggag ctggtggcca tagttacggc gccgatctaa      420

agtcatttga cttaggcgac gagcttggca ctgatcctta tgaagatttt caagaaaact      480

ggaacactaa acatagcagt ggtgttaccc gtgaactcat gcgtgagctt aacggagggg      540

catacactcg ctatgtcgat aacaacttct gtggccctga tggctaccct cttgagtgca      600

ttaaagacct tctagcacgt gctggtaaag cttcatgcac tttgtccgaa caactggact      660

ttattgacac taagaggggt gtatactgct gccgtgaaca tgagcatgaa attgcttggt      720

acacggaacg ttctgaaaag agctatgaat tgcagacacc ttttgaaatt aaattggcaa      780

agaaatttga caccttcaat ggggaatgtc caaattttgt atttccctta aattccataa      840

tcaagactat tcaaccaagg gttgaaaaga aaaagcttga tggctttatg ggtagaattc      900

gatctgtcta tccagttgcg tcaccaaatg aatgcaacca aatgtgcctt tcaactctca      960

tgaagtgtga tcattgtggt gaaacttcat ggcagacggg cgattttgtt aaagccactt     1020

gcgaattttg tggcactgag aatttgacta aagaaggtgc cactacttgt ggttacttac     1080

cccaaaatgc tgttgttaaa atttattgtc cagcatgtca caattcagaa gtaggacctg     1140

agcatagtct tgccgaatac cataatgaat ctggcttgaa aaccattctt cgtaagggtg     1200

gtcgcactat tgcctttgga ggctgtgtgt tctcttatgt tggttgccat aacaagtgtg     1260

cctattgggt tccacgtgct agcgctaaca taggttgtaa ccatacaggt gttgttggag     1320

aaggttccga aggtcttaat gacaaccttc ttgaaatact ccaaaaagag aaagtcaaca     1380

tcaatattgt tggtgacttt aaacttaatg aagagatcgc cattattttg gcatcttttt     1440

ctgcttccac aagtgctttt gtggaaactg tgaaaggttt ggattataaa gcattcaaac     1500

aaattgttga atcctgtggt aattttaaag ttacaaaagg aaaagctaaa aaaggtgcct     1560

ggaatattgg tgaacagaaa tcaatactga gtcctcttta tgcatttgca tcagaggctg     1620

ctcgtgttgt acgatcaatt ttctcccgca ctcttgaaac tgctcaaaat tctgtgcgtg     1680

ttttacagaa ggccgctata acaatactag atggaatttc acagtattca ctgagactca     1740

ttgatgctat gatgttcaca tctgatttgg ctactaacaa tctagttgta atggcctaca     1800

ttacaggtgg tgttgttcag ttgacttcgc agtggctaac taacatcttt ggcactgttt     1860

atgaaaaact caaacccgtc cttgattggc ttgaagagaa gtttaaggaa ggtgtagagt     1920

ttcttagaga cggttgggaa attgttaaat ttatctcaac ctgtgcttgt gaaattgtcg     1980

gtggacaaat tgtcacctgt gcaaaggaaa ttaaggagag tgttcagaca ttctttaagc     2040

ttgtaaataa atttttggct ttgtgtgctg actctatcat tattggtgga gctaaactta     2100

aagccttgaa tttaggtgaa acatttgtca cgcactcaaa gggattgtac agaaagtgtg     2160

ttaaatccag agaagaaact ggcctactca tgcctctaaa agccccaaaa gaaattatct     2220

tcttagaggg agaaacactt cccacagaag tgttaacaga ggaagttgtc ttgaaaactg     2280

gtgatttaca accattagaa caacctacta gtgaagctgt tgaagctcca ttggttggta     2340

caccagtttg tattaacggg cttatgttgc tcgaaatcaa agacacagaa aagtactgtg     2400

cccttgcacc taatatgatg gtaacaaaca ataccttcac actcaaaggc ggtgcaccaa     2460

caaaggttac ttttggtgat gacactgtga tagaagtgca aggttacaag agtgtgaata     2520

tcacttttga acttgatgaa aggattgata aagtacttaa tgagaagtgc tctgcctata     2580

cagttgaact cggtacagaa gtaaatgagt tcgcctgtgt tgtggcagat gctgtcataa     2640

aaactttgca accagtatct gaattactta caccactggg cattgattta gatgagtgga     2700

gtatggctac atactactta tttgatgagt ctggtgagtt taaattggct tcacatatgt     2760

attgttcttt ctaccctcca gatgaggatg aagaagaagg tgattgtgaa gaagaagagt     2820

ttgagccatc aactcaatat gagtatggta ctgaagatga ttaccaaggt aaacctttgg     2880

aatttggtgc cacttctgct gctcttcaac ctgaagaaga gcaagaagaa gattggttag     2940

atgatgatag tcaacaaact gttggtcaac aagacggcag tgaggacaat cagacaacta     3000

ctattcaaac aattgttgag gttcaacctc aattagagat ggaacttaca ccagttgttc     3060

agactattga agtgaatagt tttagtggtt atttaaaact tactgacaat gtatacatta     3120

aaaatgcaga cattgtggaa gaagctaaaa aggtaaaacc aacagtggtt gttaatgcag     3180

ccaatgttta ccttaaacat ggaggaggtg ttgcaggagc cttaaataag gctactaaca     3240

atgccatgca agttgaatct gatgattaca tagctactaa tggaccactt aaagtgggtg     3300

gtagttgtgt tttaagcgga cacaatcttg ctaaacactg tcttcatgtt gtcggcccaa     3360

atgttaacaa aggtgaagac attcaacttc ttaagagtgc ttatgaaaat tttaatcagc     3420

acgaagttct acttgcacca ttattatcag ctggtatttt tggtgctgac cctatacatt     3480

ctttaagagt ttgtgtagat actgttcgca caaatgtcta cttagctgtc tttgataaaa     3540

atctctatga caaacttgtt tcaagctttt tggaaatgaa gagtgaaaag caagttgaac     3600

aaaagatcgc tgagattcct aaagaggaag ttaagccatt tataactgaa agtaaacctt     3660

cagttgaaca gagaaaacaa gatgataaga aaatcaaagc ttgtgttgaa gaagttacaa     3720

caactctgga agaaactaag ttcctcacag aaaacttgtt actttatatt gacattaatg     3780

gcaatcttca tccagattct gccactcttg ttagtgacat tgacatcact ttcttaaaga     3840

aagatgctcc atatatagtg ggtgatgttg ttcaagaggg tgttttaact gctgtggtta     3900

tacctactaa aaaggctggt ggcactactg aaatgctagc gaaagctttg agaaaagtgc     3960

caacagacaa ttatataacc acttacccgg gtcagggttt aaatggttac actgtagagg     4020

aggcaaagac agtgcttaaa aagtgtaaaa gtgcctttta cattctacca tctattatct     4080

ctaatgagaa gcaagaaatt cttggaactg tttcttggaa tttgcgagaa atgcttgcac     4140

atgcagaaga aacacgcaaa ttaatgcctg tctgtgtgga aactaaagcc atagtttcaa     4200

ctatacagcg taaatataag ggtattaaaa tacaagaggg tgtggttgat tatggtgcta     4260

gattttactt ttacaccagt aaaacaactg tagcgtcact tatcaacaca cttaacgatc     4320

taaatgaaac tcttgttaca atgccacttg gctatgtaac acatggctta aatttggaag     4380

aagctgctcg gtatatgaga tctctcaaag tgccagctac agtttctgtt tcttcacctg     4440

atgctgttac agcgtataat ggttatctta cttcttcttc taaaacacct gaagaacatt     4500

ttattgaaac catctcactt gctggttcct ataaagattg gtcctattct ggacaatcta     4560

cacaactagg tatagaattt cttaagagag gtgataaaag tgtatattac actagtaatc     4620

ctaccacatt ccacctagat ggtgaagtta tcacctttga caatcttaag acacttcttt     4680

ctttgagaga agtgaggact attaaggtgt ttacaacagt agacaacatt aacctccaca     4740

cgcaagttgt ggacatgtca atgacatatg gacaacagtt tggtccaact tatttggatg     4800

gagctgatgt tactaaaata aaacctcata attcacatga aggtaaaaca ttttatgttt     4860

tacctaatga tgacactcta cgtgttgagg cttttgagta ctaccacaca actgatccta     4920

gttttctggg taggtacatg tcagcattaa atcacactaa aaagtggaaa tacccacaag     4980

ttaatggttt aacttctatt aaatgggcag ataacaactg ttatcttgcc actgcattgt     5040

taacactcca acaaatagag ttgaagttta atccacctgc tctacaagat gcttattaca     5100

gagcaagggc tggtgaagct gctaactttt gtgcacttat cttagcctac tgtaataaga     5160

cagtaggtga gttaggtgat gttagagaaa caatgagtta cttgtttcaa catgccaatt     5220

tagattcttg caaaagagtc ttgaacgtgg tgtgtaaaac ttgtggacaa cagcagacaa     5280

cccttaaggg tgtagaagct gttatgtaca tgggcacact ttcttatgaa caatttaaga     5340

aaggtgttca gataccttgt acgtgtggta aacaagctac aaaatatcta gtacaacagg     5400

agtcaccttt tgttatgatg tcagcaccac ctgctcagta tgaacttaag catggtacat     5460

ttacttgtgc tagtgagtac actggtaatt accagtgtgg tcactataaa catataactt     5520

ctaaagaaac tttgtattgc atagacggtg ctttacttac aaagtcctca gaatacaaag     5580

gtcctattac ggatgttttc tacaaagaaa acagttacac aacaaccata aaaccagtta     5640

cttataaatt ggatggtgtt gtttgtacag aaattgaccc taagttggac aattattata     5700

agaaagacaa ttcttatttc acagagcaac caattgatct tgtaccaaac caaccatatc     5760

caaacgcaag cttcgataat tttaagtttg tatgtgataa tatcaaattt gctgatgatt     5820

taaaccagtt aactggttat aagaaacctg cttcaagaga gcttaaagtt acatttttcc     5880

ctgacttaaa tggtgatgtg gtggctattg attataaaca ctacacaccc tcttttaaga     5940

aaggagctaa attgttacat aaacctattg tttggcatgt taacaatgca actaataaag     6000

ccacgtataa accaaatacc tggtgtatac gttgtctttg gagcacaaaa ccagttgaaa     6060

catcaaattc gtttgatgta ctgaagtcag aggacgcgca gggaatggat aatcttgcct     6120

gcgaagatct aaaaccagtc tctgaagaag tagtggaaaa tcctaccata cagaaagacg     6180

ttcttgagtg taatgtgaaa actaccgaag ttgtaggaga cattatactt aaaccagcaa     6240

ataatagttt aaaaattaca gaagaggttg gccacacaga tctaatggct gcttatgtag     6300

acaattctag tcttactatt aagaaaccta atgaattatc tagagtatta ggtttgaaaa     6360

cccttgctac tcatggttta gctgctgtta atagtgtccc ttgggatact atagctaatt     6420

atgctaagcc ttttcttaac aaagttgtta gtacaactac taacatagtt acacggtgtt     6480

taaaccgtgt ttgtactaat tatatgcctt atttctttac tttattgcta caattgtgta     6540

cttttactag aagtacaaat tctagaatta aagcatctat gccgactact atagcaaaga     6600

atactgttaa gagtgtcggt aaattttgtc tagaggcttc atttaattat ttgaagtcac     6660

ctaatttttc taaactgata aatattataa tttggttttt actattaagt gtttgcctag     6720

gttctttaat ctactcaacc gctgctttag gtgttttaat gtctaattta ggcatgcctt     6780

cttactgtac tggttacaga gaaggctatt tgaactctac taatgtcact attgcaacct     6840

actgtactgg ttctatacct tgtagtgttt gtcttagtgg tttagattct ttagacacct     6900

atccttcttt agaaactata caaattacca tttcatcttt taaatgggat ttaactgctt     6960

ttggcttagt tgcagagtgg tttttggcat atattctttt cactaggttt ttctatgtac     7020

ttggattggc tgcaatcatg caattgtttt tcagctattt tgcagtacat tttattagta     7080

attcttggct tatgtggtta ataattaatc ttgtacaaat ggccccgatt tcagctatgg     7140

ttagaatgta catcttcttt gcatcatttt attatgtatg gaaaagttat gtgcatgttg     7200

tagacggttg taattcatca acttgtatga tgtgttacaa acgtaataga gcaacaagag     7260

tcgaatgtac aactattgtt aatggtgtta gaaggtcctt ttatgtctat gctaatggag     7320

gtaaaggctt ttgcaaacta cacaattgga attgtgttaa ttgtgataca ttctgtgctg     7380

gtagtacatt tattagtgat gaagttgcga gagacttgtc actacagttt aaaagaccaa     7440

taaatcctac tgaccagtct tcttacatcg ttgatagtgt tacagtgaag aatggttcca     7500

tccatcttta ctttgataaa gctggtcaaa agacttatga aagacattct ctctctcatt     7560

ttgttaactt agacaacctg agagctaata acactaaagg ttcattgcct attaatgtta     7620

tagtttttga tggtaaatca aaatgtgaag aatcatctgc aaaatcagcg tctgtttact     7680

acagtcagct tatgtgtcaa cctatactgt tactagatca ggcattagtg tctgatgttg     7740

gtgatagtgc ggaagttgca gttaaaatgt ttgatgctta cgttaatacg ttttcatcaa     7800

cttttaacgt accaatggaa aaactcaaaa cactagttgc aactgcagaa gctgaacttg     7860

caaagaatgt gtccttagac aatgtcttat ctacttttat ttcagcagct cggcaagggt     7920

ttgttgattc agatgtagaa actaaagatg ttgttgaatg tcttaaattg tcacatcaat     7980

ctgacataga agttactggc gatagttgta ataactatat gctcacctat aacaaagttg     8040

aaaacatgac accccgtgac cttggtgctt gtattgactg tagtgcgcgt catattaatg     8100

cgcaggtagc aaaaagtcac aacattgctt tgatatggaa cgttaaagat ttcatgtcat     8160

tgtctgaaca actacgaaaa caaatacgta gtgctgctaa aaagaataac ttacctttta     8220

agttgacatg tgcaactact agacaagttg ttaatgttgt aacaacaaag atagcactta     8280

agggtggtaa aattgttaat aattggttga agcagttaat taaagttaca cttgtgttcc     8340

tttttgttgc tgctattttc tatttaataa cacctgttca tgtcatgtct aaacatactg     8400

acttttcaag tgaaatcata ggatacaagg ctattgatgg tggtgtcact cgtgacatag     8460

catctacaga tacttgtttt gctaacaaac atgctgattt tgacacatgg tttagtcagc     8520

gtggtggtag ttatactaat gacaaagctt gcccattgat tgctgcagtc ataacaagag     8580

aagtgggttt tgtcgtgcct ggtttgcctg gcacgatatt acgcacaact aatggtgact     8640

ttttgcattt cttacctaga gtttttagtg cagttggtaa catctgttac acaccatcaa     8700

aacttataga gtacactgac tttgcaacat cagcttgtgt tttggctgct gaatgtacaa     8760

tttttaaaga tgcttctggt aagccagtac catattgtta tgataccaat gtactagaag     8820

gttctgttgc ttatgaaagt ttacgccctg acacacgtta tgtgctcatg gatggctcta     8880

ttattcaatt tcctaacacc taccttgaag gttctgttag agtggtaaca acttttgatt     8940

ctgagtactg taggcacggc acttgtgaaa gatcagaagc tggtgtttgt gtatctacta     9000

gtggtagatg ggtacttaac aatgattatt acagatcttt accaggagtt ttctgtggtg     9060

tagatgctgt aaatttactt actaatatgt ttacaccact aattcaacct attggtgctt     9120

tggacatatc agcatctata gtagctggtg gtattgtagc tatcgtagta acatgccttg     9180

cctactattt tatgaggttt agaagagctt ttggtgaata cagtcatgta gttgccttta     9240

atactttact attccttatg tcattcactg tactctgttt aacaccagtt tactcattct     9300

tacctggtgt ttattctgtt atttacttgt acttgacatt ttatcttact aatgatgttt     9360

cttttttagc acatattcag tggatggtta tgttcacacc tttagtacct ttctggataa     9420

caattgctta tatcatttgt atttccacaa agcatttcta ttggttcttt agtaattacc     9480

taaagagacg tgtagtcttt aatggtgttt cctttagtac ttttgaagaa gctgcgctgt     9540

gcaccttttt gttaaataaa gaaatgtatc taaagttgcg tagtgatgtg ctattacctc     9600

ttacgcaata taatagatac ttagctcttt ataataagta caagtatttt agtggagcaa     9660

tggatacaac tagctacaga gaagctgctt gttgtcatct cgcaaaggct ctcaatgact     9720

tcagtaactc aggttctgat gttctttacc aaccaccaca aacctctatc acctcagctg     9780

ttttgcagag tggttttaga aaaatggcat tcccatctgg taaagttgag ggttgtatgg     9840

tacaagtaac ttgtggtaca actacactta acggtctttg gcttgatgac gtagtttact     9900

gtccaagaca tgtgatctgc acctctgaag acatgcttaa ccctaattat gaagatttac     9960

tcattcgtaa gtctaatcat aatttcttgg tacaggctgg taatgttcaa ctcagggtta    10020

ttggacattc tatgcaaaat tgtgtactta agcttaaggt tgatacagcc aatcctaaga    10080

cacctaagta taagtttgtt cgcattcaac caggacagac tttttcagtg ttagcttgtt    10140

acaatggttc accatctggt gtttaccaat gtgctatgag gcccaatttc actattaagg    10200

gttcattcct taatggttca tgtggtagtg ttggttttaa catagattat gactgtgtct    10260

ctttttgtta catgcaccat atggaattac caactggagt tcatgctggc acagacttag    10320

aaggtaactt ttatggacct tttgttgaca ggcaaacagc acaagcagct ggtacggaca    10380

caactattac agttaatgtt ttagcttggt tgtacgctgc tgttataaat ggagacaggt    10440

ggtttctcaa tcgatttacc acaactctta atgactttaa ccttgtggct atgaagtaca    10500

attatgaacc tctaacacaa gaccatgttg acatactagg acctctttct gctcaaactg    10560

gaattgccgt tttagatatg tgtgcttcat taaaagaatt actgcaaaat ggtatgaatg    10620

gacgtaccat attgggtagt gctttattag aagatgaatt tacacctttt gatgttgtta    10680

gacaatgctc aggtgttact ttccaaagtg cagtgaaaag aacaatcaag ggtacacacc    10740

actggttgtt actcacaatt ttgacttcac ttttagtttt agtccagagt actcaatggt    10800

ctttgttctt ttttttgtat gaaaatgcct ttttaccttt tgctatgggt attattgcta    10860

tgtctgcttt tgcaatgatg tttgtcaaac ataagcatgc atttctctgt ttgtttttgt    10920

taccttctct tgccactgta gcttatttta atatggtcta tatgcctgct agttgggtga    10980

tgcgtattat gacatggttg gatatggttg atactagttt gtctggtttt aagctaaaag    11040

actgtgttat gtatgcatca gctgtagtgt tactaatcct tatgacagca agaactgtgt    11100

atgatgatgg tgctaggaga gtgtggacac ttatgaatgt cttgacactc gtttataaag    11160

tttattatgg taatgcttta gatcaagcca tttccatgtg ggctcttata atctctgtta    11220

cttctaacta ctcaggtgta gttacaactg tcatgttttt ggccagaggt attgttttta    11280

tgtgtgttga gtattgccct attttcttca taactggtaa tacacttcag tgtataatgc    11340

tagtttattg tttcttaggc tatttttgta cttgttactt tggcctcttt tgtttactca    11400

accgctactt tagactgact cttggtgttt atgattactt agtttctaca caggagttta    11460

gatatatgaa ttcacaggga ctactcccac ccaagaatag catagatgcc ttcaaactca    11520

acattaaatt gttgggtgtt ggtggcaaac cttgtatcaa agtagccact gtacagtcta    11580

aaatgtcaga tgtaaagtgc acatcagtag tcttactctc agttttgcaa caactcagag    11640

tagaatcatc atctaaattg tgggctcaat gtgtccagtt acacaatgac attctcttag    11700

ctaaagatac tactgaagcc tttgaaaaaa tggtttcact actttctgtt ttgctttcca    11760

tgcagggtgc tgtagacata aacaagcttt gtgaagaaat gctggacaac agggcaacct    11820

tacaagctat agcctcagag tttagttccc ttccatcata tgcagctttt gctactgctc    11880

aagaagctta tgagcaggct gttgctaatg gtgattctga agttgttctt aaaaagttga    11940

agaagtcttt gaatgtggct aaatctgaat ttgaccgtga tgcagccatg caacgtaagt    12000

tggaaaagat ggctgatcaa gctatgaccc aaatgtataa acaggctaga tctgaggaca    12060

agagggcaaa agttactagt gctatgcaga caatgctttt cactatgctt agaaagttgg    12120

ataatgatgc actcaacaac attatcaaca atgcaagaga tggttgtgtt cccttgaaca    12180

taatacctct tacaacagca gccaaactaa tggttgtcat accagactat aacacatata    12240

aaaatacgtg tgatggtaca acatttactt atgcatcagc attgtgggaa atccaacagg    12300

ttgtagatgc agatagtaaa attgttcaac ttagtgaaat tagtatggac aattcaccta    12360

atttagcatg gcctcttatt gtaacagctt taagggccaa ttctgctgtc aaattacaga    12420

ataatgagct tagtcctgtt gcactacgac agatgtcttg tgctgccggt actacacaaa    12480

ctgcttgcac tgatgacaat gcgttagctt actacaacac aacaaaggga ggtaggtttg    12540

tacttgcact gttatccgat ttacaggatt tgaaatgggc tagattccct aagagtgatg    12600

gaactggtac tatctataca gaactggaac caccttgtag gtttgttaca gacacaccta    12660

aaggtcctaa agtgaagtat ttatacttta ttaaaggatt aaacaaccta aatagaggta    12720

tggtacttgg tagtttagct gccacagtac gtctacaagc tggtaatgca acagaagtgc    12780

ctgccaattc aactgtatta tctttctgtg cttttgctgt agatgctgct aaagcttaca    12840

aagattatct agctagtggg ggacaaccaa tcactaattg tgttaagatg ttgtgtacac    12900

acactggtac tggtcaggca ataacagtta caccggaagc caatatggat caagaatcct    12960

ttggtggtgc atcgtgttgt ctgtactgcc gttgccacat agatcatcca aatcctaaag    13020

gattttgtga cttaaaaggt aagtatgtac aaatacctac aacttgtgct aatgaccctg    13080

tgggttttac acttaaaaac acagtctgta ccgtctgcgg tatgtggaaa ggttatggct    13140

gtagttgtga tcaactccgc gaacccatgc ttcagtcagc tgatgcacaa tcgtttttaa    13200

ac                                                                   13202


<210>  3
<211>  8088
<212>  DNA
<213>  SARS-CoV-2

<400>  3
cgggtttgcg gtgtaagtgc agcccgtctt acaccgtgcg gcacaggcac tagtactgat       60

gtcgtataca gggcttttga catctacaat gataaagtag ctggttttgc taaattccta      120

aaaactaatt gttgtcgctt ccaagaaaag gacgaagatg acaatttaat tgattcttac      180

tttgtagtta agagacacac tttctctaac taccaacatg aagaaacaat ttataattta      240

cttaaggatt gtccagctgt tgctaaacat gacttcttta agtttagaat agacggtgac      300

atggtaccac atatatcacg tcaacgtctt actaaataca caatggcaga cctcgtctat      360

gctttaaggc attttgatga aggtaattgt gacacattaa aagaaatact tgtcacatac      420

aattgttgtg atgatgatta tttcaataaa aaggactggt atgattttgt agaaaaccca      480

gatatattac gcgtatacgc caacttaggt gaacgtgtac gccaagcttt gttaaaaaca      540

gtacaattct gtgatgccat gcgaaatgct ggtattgttg gtgtactgac attagataat      600

caagatctca atggtaactg gtatgatttc ggtgatttca tacaaaccac gccaggtagt      660

ggagttcctg ttgtagattc ttattattca ttgttaatgc ctatattaac cttgaccagg      720

gctttaactg cagagtcaca tgttgacact gacttaacaa agccttacat taagtgggat      780

ttgttaaaat atgacttcac ggaagagagg ttaaaactct ttgaccgtta ttttaaatat      840

tgggatcaga cataccaccc aaattgtgtt aactgtttgg atgacagatg cattctgcat      900

tgtgcaaact ttaatgtttt attctctaca gtgttcccac ctacaagttt tggaccacta      960

gtgagaaaaa tatttgttga tggtgttcca tttgtagttt caactggata ccacttcaga     1020

gagctaggtg ttgtacataa tcaggatgta aacttacata gctctagact tagttttaag     1080

gaattacttg tgtatgctgc tgaccctgct atgcacgctg cttctggtaa tctattacta     1140

gataaacgca ctacgtgctt ttcagtagct gcacttacta acaatgttgc ttttcaaact     1200

gtcaaacccg gtaattttaa caaagacttc tatgactttg ctgtgtctaa gggtttcttt     1260

aaggaaggaa gttctgttga attaaaacac ttcttctttg ctcaggatgg taatgctgct     1320

atcagcgatt atgactacta tcgttataat ctaccaacaa tgtgtgatat cagacaacta     1380

ctatttgtag ttgaagttgt tgataagtac tttgattgtt acgatggtgg ctgtattaat     1440

gctaaccaag tcatcgtcaa caacctagac aaatcagctg gttttccatt taataaatgg     1500

ggtaaggcta gactttatta tgattcaatg agttatgagg atcaagatgc acttttcgca     1560

tatacaaaac gtaatgtcat ccctactata actcaaatga atcttaagta tgccattagt     1620

gcaaagaata gagctcgcac cgtagctggt gtctctatct gtagtactat gaccaataga     1680

cagtttcatc aaaaattatt gaaatcaata gccgccacta gaggagctac tgtagtaatt     1740

ggaacaagca aattctatgg tggttggcac aacatgttaa aaactgttta tagtgatgta     1800

gaaaaccctc accttatggg ttgggattat cctaaatgtg atagagccat gcctaacatg     1860

cttagaatta tggcctcact tgttcttgct cgcaaacata caacgtgttg tagcttgtca     1920

caccgtttct atagattagc taatgagtgt gctcaagtat tgagtgaaat ggtcatgtgt     1980

ggcggttcac tatatgttaa accaggtgga acctcatcag gagatgccac aactgcttat     2040

gctaatagtg tttttaacat ttgtcaagct gtcacggcca atgttaatgc acttttatct     2100

actgatggta acaaaattgc cgataagtat gtccgcaatt tacaacacag actttatgag     2160

tgtctctata gaaatagaga tgttgacaca gactttgtga atgagtttta cgcatatttg     2220

cgtaaacatt tctcaatgat gatactctct gacgatgctg ttgtgtgttt caatagcact     2280

tatgcatctc aaggtctagt ggctagcata aagaacttta agtcagttct ttattatcaa     2340

aacaatgttt ttatgtctga agcaaaatgt tggactgaga ctgaccttac taaaggacct     2400

catgaatttt gctctcaaca tacaatgcta gttaaacagg gtgatgatta tgtgtacctt     2460

ccttacccag atccatcaag aatcctaggg gccggctgtt ttgtagatga tatcgtaaaa     2520

acagatggta cacttatgat tgaacggttc gtgtctttag ctatagatgc ttacccactt     2580

actaaacatc ctaatcagga gtatgctgat gtctttcatt tgtacttaca atacataaga     2640

aagctacatg atgagttaac aggacacatg ttagacatgt attctgttat gcttactaat     2700

gataacactt caaggtattg ggaacctgag ttttatgagg ctatgtacac accgcataca     2760

gtcttacagg ctgttggggc ttgtgttctt tgcaattcac agacttcatt aagatgtggt     2820

gcttgcatac gtagaccatt cttatgttgt aaatgctgtt acgaccatgt catatcaaca     2880

tcacataaat tagtcttgtc tgttaatccg tatgtttgca atgctccagg ttgtgatgtc     2940

acagatgtga ctcaacttta cttaggaggt atgagctatt attgtaaatc acataaacca     3000

cccattagtt ttccattgtg tgctaatgga caagtttttg gtttatataa aaatacatgt     3060

gttggtagcg ataatgttac tgactttaat gcaattgcaa catgtgactg gacaaatgct     3120

ggtgattaca ttttagctaa cacctgtact gaaagactca agctttttgc agcagaaacg     3180

ctcaaagcta ctgaggagac atttaaactg tcttatggta ttgctactgt acgtgaagtg     3240

ctgtctgaca gagaattaca tctttcatgg gaagttggta aacctagacc accacttaac     3300

cgaaattatg tctttactgg ttatcgtgta actaaaaaca gtaaagtaca aataggagag     3360

tacacctttg aaaaaggtga ctatggtgat gctgttgttt accgaggtac aacaacttac     3420

aaattaaatg ttggtgatta ttttgtgctg acatcacata cagtaatgcc attaagtgca     3480

cctacactag tgccacaaga gcactatgtt agaattactg gcttataccc aacactcaat     3540

atctcagatg agttttctag caatgttgca aattatcaaa aggttggtat gcaaaagtat     3600

tctacactcc agggaccacc tggtactggt aagagtcatt ttgctattgg cctagctctc     3660

tactaccctt ctgctcgcat agtgtataca gcttgctctc atgccgctgt tgatgcacta     3720

tgtgagaagg cattaaaata tttgcctata gataaatgta gtagaattat acctgcacgt     3780

gctcgtgtag agtgttttga taaattcaaa gtgaattcaa cattagaaca gtatgtcttt     3840

tgtactgtaa atgcattgcc tgagacgaca gcagatatag ttgtctttga tgaaatttca     3900

atggccacaa attatgattt gagtgttgtc aatgccagat tacgtgctaa gcactatgtg     3960

tacattggcg accctgctca attacctgca ccacgcacat tgctaactaa gggcacacta     4020

gaaccagaat atttcaattc agtgtgtaga cttatgaaaa ctataggtcc agacatgttc     4080

ctcggaactt gtcggcgttg tcctgctgaa attgttgaca ctgtgagtgc tttggtttat     4140

gataataagc ttaaagcaca taaagacaaa tcagctcaat gctttaaaat gttttataag     4200

ggtgttatca cgcatgatgt ttcatctgca attaacaggc cacaaatagg cgtggtaaga     4260

gaattcctta cacgtaaccc tgcttggaga aaagctgtct ttatttcacc ttataattca     4320

cagaatgctg tagcctcaaa gattttggga ctaccaactc aaactgttga ttcatcacag     4380

ggctcagaat atgactatgt catattcact caaaccactg aaacagctca ctcttgtaat     4440

gtaaacagat ttaatgttgc tattaccaga gcaaaagtag gcatactttg cataatgtct     4500

gatagagacc tttatgacaa gttgcaattt acaagtcttg aaattccacg taggaatgtg     4560

gcaactttac aagctgaaaa tgtaacagga ctttttaaag attgtagtaa ggtaatcact     4620

gggttacatc ctacacaggc acctacacac ctcagtgttg acactaaatt caaaactgaa     4680

ggtttatgtg ttgacatacc tggcatacct aaggacatga cctatagaag actcatctct     4740

atgatgggtt ttaaaatgaa ttatcaagtt aatggttacc ctaacatgtt tatcacccgc     4800

gaagaagcta taagacatgt acgtgcatgg attggcttcg atgtcgaggg gtgtcatgct     4860

actagagaag ctgttggtac caatttacct ttacagctag gtttttctac aggtgttaac     4920

ctagttgctg tacctacagg ttatgttgat acacctaata atacagattt ttccagagtt     4980

agtgctaaac caccgcctgg agatcaattt aaacacctca taccacttat gtacaaagga     5040

cttccttgga atgtagtgcg tataaagatt gtacaaatgt taagtgacac acttaaaaat     5100

ctctctgaca gagtcgtatt tgtcttatgg gcacatggct ttgagttgac atctatgaag     5160

tattttgtga aaataggacc tgagcgcacc tgttgtctat gtgatagacg tgccacatgc     5220

ttttccactg cttcagacac ttatgcctgt tggcatcatt ctattggatt tgattacgtc     5280

tataatccgt ttatgattga tgttcaacaa tggggtttta caggtaacct acaaagcaac     5340

catgatctgt attgtcaagt ccatggtaat gcacatgtag ctagttgtga tgcaatcatg     5400

actaggtgtc tagctgtcca cgagtgcttt gttaagcgtg ttgactggac tattgaatat     5460

cctataattg gtgatgaact gaagattaat gcggcttgta gaaaggttca acacatggtt     5520

gttaaagctg cattattagc agacaaattc ccagttcttc acgacattgg taaccctaaa     5580

gctattaagt gtgtacctca agctgatgta gaatggaagt tctatgatgc acagccttgt     5640

agtgacaaag cttataaaat agaagaatta ttctattctt atgccacaca ttctgacaaa     5700

ttcacagatg gtgtatgcct attttggaat tgcaatgtcg atagatatcc tgctaattcc     5760

attgtttgta gatttgacac tagagtgcta tctaacctta acttgcctgg ttgtgatggt     5820

ggcagtttgt atgtaaataa acatgcattc cacacaccag cttttgataa aagtgctttt     5880

gttaatttaa aacaattacc atttttctat tactctgaca gtccatgtga gtctcatgga     5940

aaacaagtag tgtcagatat agattatgta ccactaaagt ctgctacgtg tataacacgt     6000

tgcaatttag gtggtgctgt ctgtagacat catgctaatg agtacagatt gtatctcgat     6060

gcttataaca tgatgatctc agctggcttt agcttgtggg tttacaaaca atttgatact     6120

tataacctct ggaacacttt tacaagactt cagagtttag aaaatgtggc ttttaatgtt     6180

gtaaataagg gacactttga tggacaacag ggtgaagtac cagtttctat cattaataac     6240

actgtttaca caaaagttga tggtgttgat gtagaattgt ttgaaaataa aacaacatta     6300

cctgttaatg tagcatttga gctttgggct aagcgcaaca ttaaaccagt accagaggtg     6360

aaaatactca ataatttggg tgtggacatt gctgctaata ctgtgatctg ggactacaaa     6420

agagatgctc cagcacatat atctactatt ggtgtttgtt ctatgactga catagccaag     6480

aaaccaactg aaacgatttg tgcaccactc actgtctttt ttgatggtag agttgatggt     6540

caagtagact tatttagaaa tgcccgtaat ggtgttctta ttacagaagg tagtgttaaa     6600

ggtttacaac catctgtagg tcccaaacaa gctagtctta atggagtcac attaattgga     6660

gaagccgtaa aaacacagtt caattattat aagaaagttg atggtgttgt ccaacaatta     6720

cctgaaactt actttactca gagtagaaat ttacaagaat ttaaacccag gagtcaaatg     6780

gaaattgatt tcttagaatt agctatggat gaattcattg aacggtataa attagaaggc     6840

tatgccttcg aacatatcgt ttatggagat tttagtcata gtcagttagg tggtttacat     6900

ctactgattg gactagctaa acgttttaag gaatcacctt ttgaattaga agattttatt     6960

cctatggaca gtacagttaa aaactatttc ataacagatg cgcaaacagg ttcatctaag     7020

tgtgtgtgtt ctgttattga tttattactt gatgattttg ttgaaataat aaaatcccaa     7080

gatttatctg tagtttctaa ggttgtcaaa gtgactattg actatacaga aatttcattt     7140

atgctttggt gtaaagatgg ccatgtagaa acattttacc caaaattaca atctagtcaa     7200

gcgtggcaac cgggtgttgc tatgcctaat ctttacaaaa tgcaaagaat gctattagaa     7260

aagtgtgacc ttcaaaatta tggtgatagt gcaacattac ctaaaggcat aatgatgaat     7320

gtcgcaaaat atactcaact gtgtcaatat ttaaacacat taacattagc tgtaccctat     7380

aatatgagag ttatacattt tggtgctggt tctgataaag gagttgcacc aggtacagct     7440

gttttaagac agtggttgcc tacgggtacg ctgcttgtcg attcagatct taatgacttt     7500

gtctctgatg cagattcaac tttgattggt gattgtgcaa ctgtacatac agctaataaa     7560

tgggatctca ttattagtga tatgtacgac cctaagacta aaaatgttac aaaagaaaat     7620

gactctaaag agggtttttt cacttacatt tgtgggttta tacaacaaaa gctagctctt     7680

ggaggttccg tggctataaa gataacagaa cattcttgga atgctgatct ttataagctc     7740

atgggacact tcgcatggtg gacagccttt gttactaatg tgaatgcgtc atcatctgaa     7800

gcatttttaa ttggatgtaa ttatcttggc aaaccacgcg aacaaataga tggttatgtc     7860

atgcatgcaa attacatatt ttggaggaat acaaatccaa ttcagttgtc ttcctattct     7920

ttatttgaca tgagtaaatt tccccttaaa ttaaggggta ctgctgttat gtctttaaaa     7980

gaaggtcaaa tcaatgatat gattttatct cttcttagta aaggtagact tataattaga     8040

gaaaacaaca gagttgttat ttctagtgat gttcttgtta acaactaa                  8088


<210>  4
<211>  117
<212>  DNA
<213>  SARS-CoV-2

<400>  4
atgggctata taaacgtttt cgcttttccg tttacgatat atagtctact cttgtgcaga       60

atgaattctc gtaactacat agcacaagta gatgtagtta actttaatct cacatag         117


<210>  5
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  5
cactagtctc tagtcagtgt gttaa                                             25


<210>  6
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  6
ccaatgttac ttggttccat gctat                                             25


<210>  7
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  7
tagaagttat ttgactcctg gtgat                                             25


<210>  8
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  8
cagcaactgt gttgctgatt attct                                             25


<210>  9
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  9
tggtgcaggt atatgcgcta gttat                                             25


<210>  10
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  10
cgctagttat cagactcaga ctaat                                             25


<210>  11
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  11
cacaagcttt aaacacgctt gttaa                                             25


<210>  12
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  12
cctcatggtg tagtcttctt gcatg                                             25


<210>  13
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  13
ccgcctcaat gaggttgcca agaat                                             25


<210>  14
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  14
ggccatggta catttggcta ggttt                                             25


<210>  15
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  15
ccgtttacga tatatagtct actct                                             25


<210>  16
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  16
acgatatata gtctactctt gtgca                                             25


<210>  17
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  17
tagtctactc ttgtgcagaa tgaat                                             25


<210>  18
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  18
agtctactct tgtgcagaat gaatt                                             25


<210>  19
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  19
tcttgtgcag aatgaattct cgtaa                                             25


<210>  20
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  20
tgtgcagaat gaattctcgt aacta                                             25


<210>  21
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  21
tgcagaatga attctcgtaa ctaca                                             25


<210>  22
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  22
gcagaatgaa ttctcgtaac tacat                                             25


<210>  23
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  23
tgaattctcg taactacata gcaca                                             25


<210>  24
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  24
tcgtaactac atagcacaag tagat                                             25


<210>  25
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  25
cagtttgtat taacgggctt atgtt                                             25


<210>  26
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  26
caatgccatg caagttgaat ctgat                                             25


<210>  27
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  27
gcacgaagtt ctacttgcac catta                                             25


<210>  28
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  28
cacacgcaag ttgtggacat gtcaa                                             25


<210>  29
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  29
ccacacagat ctaatggctg cttat                                             25


<210>  30
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  30
cacagatcta atggctgctt atgta                                             25


<210>  31
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  31
cagtcagctt atgtgtcaac ctata                                             25


<210>  32
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  32
cagctgtagt gttactaatc cttat                                             25


<210>  33
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  33
tagaggtatg gtacttggta gttta                                             25


<210>  34
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  34
ccgtctgcgg tatgtggaaa ggtta                                             25


<210>  35
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  35
cacagacttt atgagtgtct ctata                                             25


<210>  36
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  36
caggagtatg ctgatgtctt tcatt                                             25


<210>  37
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  37
caaagctact gaggagacat ttaaa                                             25


<210>  38
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  38
catctgcaat taacaggcca caaat                                             25


<210>  39
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  39
cagaatgctg tagcctcaaa gattt                                             25


<210>  40
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  40
caagctgatg tagaatggaa gttct                                             25


<210>  41
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  41
gatttgacac tagagtgcta tctaa                                             25


<210>  42
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  42
cagctggctt tagcttgtgg gttta                                             25


<210>  43
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  43
gagctttggg ctaagcgcaa catta                                             25


<210>  44
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Based on SARS-CoV-2

<400>  44
cgggtgttgc tatgcctaat cttta                                             25


<210>  45
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  45

Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu 
            20      


<210>  46
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  46

Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu Ser Thr Leu Trp Asp Thr Ala Glu Leu Trp Gln 
            20                  25                  30          


<210>  47
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  47

Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30          


<210>  48
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  48

Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu Thr Tyr Ala Asp Phe Ile Ala Ser Gly Arg Thr 
            20                  25                  30          


Gly Arg Arg Asn Ala Ile 
        35              


<210>  49
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  49

Cys Gly Tyr Gly Pro Lys Lys Lys Arg Lys Val Gly Gly 
1               5                   10              


<210>  50
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  50

Cys Ser Ile Pro Pro Glu Val Lys Phe Asn Pro Phe Val Tyr Leu Ile 
1               5                   10                  15      


<210>  51
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  51

Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210>  52
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  52

Gly Ile Gly Ala Val Leu Lys Val Leu Thr Thr Gly Leu Pro Ala Leu 
1               5                   10                  15      


Ile Ser Trp Ile Lys Arg Lys Arg Gln Gln 
            20                  25      


<210>  53
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  53

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210>  54
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  54

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ser Thr Leu 
1               5                   10                  15      


Trp Asp Thr Ala Glu Leu Trp Gln 
            20                  


<210>  55
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  55

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Thr Ala Leu 
1               5                   10                  15      


Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  


<210>  56
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  56

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Thr Tyr Ala 
1               5                   10                  15      


Asp Phe Ile Ala Ser Gly Arg Thr Gly Arg Arg Asn Ala Ile 
            20                  25                  30  


<210>  57
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  57

Gly Arg Pro Arg Glu Ser Gly Lys Lys Arg Lys Arg Lys Arg Leu Lys 
1               5                   10                  15      


Pro 
    


<210>  58
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  58

Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210>  59
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  59

Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210>  60
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  60

His Gly Leu Ala Ser Thr Leu Thr Arg Trp Ala His Tyr Asn Ala Leu 
1               5                   10                  15      


Ile Arg Ala Phe 
            20  


<210>  61
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  61

Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210>  62
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  62

Lys Lys Lys Lys Lys Lys Lys Lys 
1               5               


<210>  63
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  63

Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210>  64
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  64

Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


<210>  65
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  65

Leu Ser Thr Ala Ala Asp Met Gln Gly Val Val Thr Asp Gly Met Ala 
1               5                   10                  15      


Ser Gly Leu Asp Lys Asp Tyr Leu Lys Pro Asp Asp 
            20                  25              


<210>  66
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  66

Met Val Arg Arg Phe Leu Val Thr Leu Arg Ile Arg Arg Ala Cys Gly 
1               5                   10                  15      


Pro Pro Arg Val Arg Val 
            20          


<210>  67
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  67

Arg Lys Lys Arg Arg Arg Glu Ser Arg Lys Lys Arg Arg Arg Glu Ser 
1               5                   10                  15      


<210>  68
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  68

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  69
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  69

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Ser Thr Leu Trp Asp Thr Ala Glu Leu Trp Gln 
            20                  25          


<210>  70
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  70

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210>  71
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  71

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Thr Tyr Ala Asp Phe Ile Ala Ser Gly Arg Thr Gly Arg Arg Asn Ala 
            20                  25                  30          


Ile 
    


<210>  72
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  72

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  73
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(12)
<223>  Each may be independently present or absent

<400>  73

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10              


<210>  74
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  74

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Ser Thr Leu Trp Asp 
1               5                   10                  15      


Thr Ala Glu Leu Trp Gln 
            20          


<210>  75
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  75

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Thr Ala Leu Asp Trp 
1               5                   10                  15      


Ser Trp Leu Gln Thr Glu 
            20          


<210>  76
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  76

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Thr Tyr Ala Asp Phe 
1               5                   10                  15      


Ile Ala Ser Gly Arg Thr Gly Arg Arg Asn Ala Ile 
            20                  25              


<210>  77
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  77

Arg Arg Trp Trp Arg Arg Trp Arg Arg 
1               5                   


<210>  78
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  78

Arg Val Arg Val Phe Val Val His Ile Pro Arg Leu Thr 
1               5                   10              


<210>  79
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  79

Val Ser Ala Leu Lys 
1               5   


<210>  80
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cell-penetrating peptide

<400>  80

Leu Leu Leu Leu Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10          


<210>  81
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  81

Gly Ser Asn Arg Glu Cys His Ala Leu Phe Cys Met Asp Phe Ala Pro 
1               5                   10                  15      


Gly Glu Gly Gly Gly 
            20      


<210>  82
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  82

Gly Ser Ser Pro Thr Cys Arg Ala Leu Phe Cys Val Asp Phe Ala Pro 
1               5                   10                  15      


Gly Glu Gly Gly Gly 
            20      


<210>  83
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  83

Gly Ser Leu Glu Met Cys Glu Ala Leu Phe Cys Val Glu Phe Ala Pro 
1               5                   10                  15      


Gly Glu Gly Gly Gly 
            20      


<210>  84
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  84

Gly Ser Asn Asp Tyr Cys Thr Val Phe Thr Gly Ala Leu Phe Cys Leu 
1               5                   10                  15      


Asp Phe Ala Pro Glu Gly Gly Gly 
            20                  


<210>  85
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  85

Gly Ser Pro Asn Gln Cys Gly Val Asp Ile Trp Ala Leu Phe Cys Val 
1               5                   10                  15      


Asp Phe Ala Pro Glu Gly Gly Gly Lys 
            20                  25  


<210>  86
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  86

Ala Gly Glu Gly Asn Cys Phe Leu Ile Gly Pro Trp Cys Phe Glu Phe 
1               5                   10                  15      


Gly Thr Glu Gly Gly Gly 
            20          


<210>  87
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  87

Gly Ser Tyr Asp Asn Cys Leu Gly Leu Ala Asn Leu Asn Phe Cys Phe 
1               5                   10                  15      


Asp Phe Ala Pro Glu Gly Gly Gly 
            20                  


<210>  88
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  88

Gly Asp Asp Asp Asp Cys Gly Trp Ile Gly Phe Ala Asn Phe His Leu 
1               5                   10                  15      


Cys Leu His Gly Asp Pro Glu Gly Gly Gly 
            20                  25      


<210>  89
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  89

Gly Asp Pro Phe Glu Cys Asp Trp Gly Pro Trp Thr Leu Glu Met Leu 
1               5                   10                  15      


Cys Gly Pro Pro Asp Pro Glu Gly Gly Gly 
            20                  25      


<210>  90
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  90

Gly Ser Arg Ile Gly Cys Arg Asp Ser Arg Cys Asn Trp Trp Ala Pro 
1               5                   10                  15      


Gly Glu Gly Gly Gly 
            20      


<210>  91
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  91

Gly Ser Arg Gly Phe Cys Arg Asp Ser Ser Cys Ser Phe Pro Ala Pro 
1               5                   10                  15      


Gly Glu Gly Gly Gly 
            20      


<210>  92
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  92

Gly Ser Trp Pro Thr Cys Leu Thr Met Asp Cys Val Tyr Asn Ala Pro 
1               5                   10                  15      


Gly Glu Gly Gly Gly 
            20      


<210>  93
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  93

Ala Gly Trp Val Leu Cys Phe Glu Trp Glu Asp Cys Asp Glu Lys Gly 
1               5                   10                  15      


Thr Glu Gly Gly Gly 
            20      


<210>  94
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  94

Ala Gly Val Tyr Phe Cys Phe Asp Trp Glu Gln Asp Cys Asp Glu Met 
1               5                   10                  15      


Gly Thr Glu Gly Gly Gly 
            20          


<210>  95
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  95

Ala Gly Trp Glu Val Cys His Trp Ala Pro Met Met Cys Lys His Gly 
1               5                   10                  15      


Gly Thr Glu Gly Gly Gly 
            20          


<210>  96
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  96

Ala Gly Gln Lys Glu Cys Lys Phe Gly Tyr Pro His Cys Leu Pro Trp 
1               5                   10                  15      


Gly Thr Glu Gly Gly Gly 
            20          


<210>  97
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  97

Ala Gly Ser Asp Trp Cys Gly Thr Trp Asn Asn Pro Cys Phe His Gln 
1               5                   10                  15      


Gly Thr Glu Gly Gly Gly 
            20          


<210>  98
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  98

Gly Asp Arg Leu His Cys Lys Pro Gln Arg Gln Ser Pro Trp Met Lys 
1               5                   10                  15      


Cys Gln His Leu Asp Pro Glu Gly Gly Gly 
            20                  25      


<210>  99
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  99

Gly Asp Leu His Ala Cys Arg Pro Val Arg Gly Asp Pro Trp Trp Ala 
1               5                   10                  15      


Cys Thr Leu Gly Asp Pro Glu Gly Gly Gly 
            20                  25      


<210>  100
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  100

Gly Asp Arg Tyr Leu Cys Leu Pro Gln Arg Asp Lys Pro Trp Lys Phe 
1               5                   10                  15      


Cys Asn Trp Phe Asp Pro Glu Gly Gly Gly 
            20                  25      


<210>  101
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  101

Gly Asp Tyr Ser His Cys Ser Pro Leu Arg Tyr Tyr Pro Trp Trp Lys 
1               5                   10                  15      


Cys Thr Tyr Pro Asp Pro Glu Gly Gly Gly 
            20                  25      


<210>  102
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  102

Gly Asp Gly Phe Thr Cys Ser Pro Ile Arg Met Phe Pro Trp Phe Arg 
1               5                   10                  15      


Cys Asp Leu Gly Asp Pro Glu Gly Gly Gly 
            20                  25      


<210>  103
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide

<400>  103

Gly Asp Phe Ser Pro Cys Lys Ala Leu Arg His Ser Pro Trp Trp Val 
1               5                   10                  15      


Cys Pro Ser Gly Asp Pro Glu Gly Gly Gly 
            20                  25      


<210>  104
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 receptor binding peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  wherein Xaa is any amino acid, preferably K, R, L, or S

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  wherein Xaa is any amino acid, preferably Q, V, L, or I

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  wherein Xaa is any amino acid, preferably Q, G, D, Y, M, or H

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  wherein Xaa is any amino acid, preferably S, D, K, Y, or F

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  wherein Xaa is any amino acid, preferably M, W, K, or F

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  wherein Xaa is any amino acid, preferably K, A, F, R, or V

<400>  104

Cys Xaa Pro Xaa Arg Xaa Xaa Pro Trp Xaa Xaa Cys 
1               5                   10          


<210>  105
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RNase peptide sequence

<400>  105

Tyr Val Asp Gly Ala Ala Ser Arg Glu Thr Lys Ser Gly Lys Ala Gly 
1               5                   10                  15      


Tyr Val Thr Asp Arg Gly Arg Gln Lys Val Val Ser Leu Thr Glu Thr 
            20                  25                  30          


Thr Asn Gln Lys Thr Glu Leu Gln Ala Ile His Leu Ala Leu Gln Asp 
        35                  40                  45              


Ser Gly Leu Glu Val Asn Ile Val Thr Asp Ser Gln Tyr Ala Leu Gly 
    50                  55                  60                  


Ile Ile Gln Ala Gln Pro Asp Lys Ser Glu Ser Glu Leu Val Ser Gln 
65                  70                  75                  80  


Ile Ile Glu Gln Leu Ile Asn Lys Glu Lys Val Tyr Leu Ala Trp Val 
                85                  90                  95      


Pro Ala His Lys Gly Ile Gly Gly Asn Glu Gln Val Asp Lys Leu Val 
            100                 105                 110         


Ser Ser Gly Ile Arg Lys Val Leu 
        115                 120 


<210>  106
<211>  155
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RNase peptide sequence

<400>  106

Met Leu Lys Gln Val Glu Ile Phe Thr Asp Gly Ser Cys Leu Gly Asn 
1               5                   10                  15      


Pro Gly Pro Gly Gly Tyr Gly Ala Ile Leu Arg Tyr Arg Gly Arg Glu 
            20                  25                  30          


Lys Thr Phe Ser Ala Gly Tyr Thr Arg Thr Thr Asn Asn Arg Met Glu 
        35                  40                  45              


Leu Met Ala Ala Ile Val Ala Leu Glu Ala Leu Lys Glu His Cys Glu 
    50                  55                  60                  


Val Ile Leu Ser Thr Asp Ser Gln Tyr Val Arg Gln Gly Ile Thr Gln 
65                  70                  75                  80  


Trp Ile His Asn Trp Lys Lys Arg Gly Trp Lys Thr Ala Asp Lys Lys 
                85                  90                  95      


Pro Val Lys Asn Val Asp Leu Trp Gln Arg Leu Asp Ala Ala Leu Gly 
            100                 105                 110         


Gln His Gln Ile Lys Trp Glu Trp Val Lys Gly His Ala Gly His Pro 
        115                 120                 125             


Glu Asn Glu Arg Cys Asp Glu Leu Ala Arg Ala Ala Ala Met Asn Pro 
    130                 135                 140                 


Thr Leu Glu Asp Thr Gly Tyr Gln Val Glu Val 
145                 150                 155 


<210>  107
<211>  150
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RNase peptide sequence

<400>  107

Met Tyr Gln Leu Glu Lys Glu Pro Ile Val Gly Ala Glu Thr Phe Tyr 
1               5                   10                  15      


Val Asp Gly Ala Ala Asn Arg Glu Thr Lys Leu Gly Lys Ala Gly Tyr 
            20                  25                  30          


Val Thr Asn Arg Gly Arg Gln Lys Val Val Thr Leu Thr Asp Thr Thr 
        35                  40                  45              


Asn Gln Lys Thr Glu Leu Gln Ala Ile Tyr Leu Ala Leu Gln Asp Ser 
    50                  55                  60                  


Gly Leu Glu Val Asn Ile Val Thr Asp Ser Gln Tyr Ala Leu Gly Ile 
65                  70                  75                  80  


Ile Thr Gln Trp Ile His Asn Trp Lys Lys Arg Gly Trp Lys Thr Ala 
                85                  90                  95      


Asp Lys Lys Pro Val Lys Asn Val Asp Leu Val Asn Gln Ile Ile Glu 
            100                 105                 110         


Gln Leu Ile Lys Lys Glu Lys Val Tyr Leu Ala Trp Val Pro Ala His 
        115                 120                 125             


Lys Gly Ile Gly Gly Asn Glu Gln Val Asp Lys Leu Val Ser Ala Gly 
    130                 135                 140                 


Ile Arg Lys Val Leu Phe 
145                 150 


<210>  108
<211>  192
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RNase peptide sequence

<400>  108

Met Val Ser Val Ser Arg Thr Ile Trp Arg Val Ile Ala Val Leu Ile 
1               5                   10                  15      


Ala Val Ile Tyr Val Arg Leu Ile Val Leu Gln Phe Asp Ser Ile Thr 
            20                  25                  30          


Gly Ser Leu Pro Glu Met Leu Lys Gln Val Glu Ile Phe Thr Asp Gly 
        35                  40                  45              


Ser Cys Leu Gly Asn Pro Gly Pro Gly Gly Tyr Gly Ala Ile Leu Arg 
    50                  55                  60                  


Tyr Arg Gly Arg Glu Lys Thr Phe Ser Ala Gly Tyr Thr Arg Thr Thr 
65                  70                  75                  80  


Asn Asn Arg Met Glu Leu Met Ala Ala Ile Val Ala Leu Glu Ala Leu 
                85                  90                  95      


Lys Glu His Cys Glu Val Ile Leu Ser Thr Asp Ser Gln Tyr Val Arg 
            100                 105                 110         


Gln Gly Ile Thr Gln Trp Ile His Asn Trp Lys Lys Arg Gly Trp Lys 
        115                 120                 125             


Thr Ala Asp Lys Lys Pro Val Lys Asn Val Asp Leu Trp Gln Arg Leu 
    130                 135                 140                 


Asp Ala Ala Leu Gly Gln His Gln Ile Lys Trp Glu Trp Val Lys Gly 
145                 150                 155                 160 


His Ala Gly His Pro Glu Asn Glu Arg Cys Asp Glu Leu Ala Arg Ala 
                165                 170                 175     


Ala Ala Met Asn Pro Thr Leu Glu Asp Thr Gly Tyr Gln Val Glu Val 
            180                 185                 190         


<210>  109
<211>  154
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RNase peptide sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa may be present or absent, and if present, Xaa may be any 
       amino acid, preferably M or L

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa may be present or absent, and if present, Xaa may be any 
       amino acid, preferably Y or K

<400>  109

Xaa Xaa Gln Val Glu Ile Phe Thr Asp Gly Ser Cys Leu Gly Asn Pro 
1               5                   10                  15      


Gly Pro Gly Gly Tyr Gly Ala Ile Leu Arg Tyr Arg Gly Arg Glu Lys 
            20                  25                  30          


Thr Phe Ser Ala Gly Tyr Thr Arg Thr Thr Asn Asn Arg Met Glu Leu 
        35                  40                  45              


Met Ala Ala Ile Val Ala Leu Glu Ala Leu Lys Glu His Cys Glu Val 
    50                  55                  60                  


Ile Leu Ser Thr Asp Ser Gln Tyr Val Leu Gln Gly Ile Thr Gln Trp 
65                  70                  75                  80  


Ile His Asn Trp Lys Lys Arg Gly Trp Lys Thr Ala Asp Lys Lys Pro 
                85                  90                  95      


Val Lys Asn Val Asp Leu Trp Gln Arg Leu Asp Ala Ala Leu Gly Gln 
            100                 105                 110         


His Gln Ile Lys Trp Glu Trp Tyr Lys Gly His Ala Gly His Pro Glu 
        115                 120                 125             


Asn Glu Arg Cys Asp Glu Leu Ala Arg Ala Ala Ala Met Asn Pro Thr 
    130                 135                 140                 


Leu Glu Asp Thr Gly Tyr Gln Val Glu Val 
145                 150                 


<210>  110
<211>  150
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RNase peptide sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa may be present or absent and, if Xaa is present, Xaa may be 
       any amino acid, preferably M

<220>
<221>  MISC_FEATURE
<222>  (102)..(102)
<223>  Xaa may be present or absent and, if Xaa is present, Xaa may be 
       any amino acid, preferably V

<400>  110

Xaa Met Tyr Gln Leu Glu Lys Glu Pro Ile Val Gly Ala Glu Thr Phe 
1               5                   10                  15      


Tyr Val Asp Gly Ala Ala Asn Arg Glu Thr Lys Leu Gly Lys Ala Gly 
            20                  25                  30          


Tyr Val Thr Asn Arg Gly Arg Gln Lys Val Val Thr Leu Thr Asp Thr 
        35                  40                  45              


Thr Asn Gln Lys Thr Glu Leu Gln Ala Ile Tyr Leu Ala Leu Gln Asp 
    50                  55                  60                  


Ser Gly Leu Glu Val Asn Ile Val Thr Asp Ser Gln Tyr Ala Leu Gln 
65                  70                  75                  80  


Gly Ile Thr Gln Trp Ile His Asn Trp Lys Lys Arg Gly Trp Lys Thr 
                85                  90                  95      


Ala Asp Lys Lys Pro Xaa Lys Asn Val Asp Leu Val Asn Gln Ile Ile 
            100                 105                 110         


Glu Gln Leu Ile Lys Lys Glu Lys Val Tyr Leu Ala Trp Val Pro Ala 
        115                 120                 125             


His Lys Gly Ile Gly Gly Asn Glu Gln Val Asp Lys Leu Val Ser Ala 
    130                 135                 140                 


Gly Ile Arg Lys Val Leu 
145                 150 


<210>  111
<211>  859
<212>  PRT
<213>  Homo sapiens

<400>  111

Met Tyr Ser Gly Ala Gly Pro Ala Leu Ala Pro Pro Ala Pro Pro Pro 
1               5                   10                  15      


Pro Ile Gln Gly Tyr Ala Phe Lys Pro Pro Pro Arg Pro Asp Phe Gly 
            20                  25                  30          


Thr Ser Gly Arg Thr Ile Lys Leu Gln Ala Asn Phe Phe Glu Met Asp 
        35                  40                  45              


Ile Pro Lys Ile Asp Ile Tyr His Tyr Glu Leu Asp Ile Lys Pro Glu 
    50                  55                  60                  


Lys Cys Pro Arg Arg Val Asn Arg Glu Ile Val Glu His Met Val Gln 
65                  70                  75                  80  


His Phe Lys Thr Gln Ile Phe Gly Asp Arg Lys Pro Val Phe Asp Gly 
                85                  90                  95      


Arg Lys Asn Leu Tyr Thr Ala Met Pro Leu Pro Ile Gly Arg Asp Lys 
            100                 105                 110         


Val Glu Leu Glu Val Thr Leu Pro Gly Glu Gly Lys Asp Arg Ile Phe 
        115                 120                 125             


Lys Val Ser Ile Lys Trp Val Ser Cys Val Ser Leu Gln Ala Leu His 
    130                 135                 140                 


Asp Ala Leu Ser Gly Arg Leu Pro Ser Val Pro Phe Glu Thr Ile Gln 
145                 150                 155                 160 


Ala Leu Asp Val Val Met Arg His Leu Pro Ser Met Arg Tyr Thr Pro 
                165                 170                 175     


Val Gly Arg Ser Phe Phe Thr Ala Ser Glu Gly Cys Ser Asn Pro Leu 
            180                 185                 190         


Gly Gly Gly Arg Glu Val Trp Phe Gly Phe His Gln Ser Val Arg Pro 
        195                 200                 205             


Ser Leu Trp Lys Met Met Leu Asn Ile Asp Val Ser Ala Thr Ala Phe 
    210                 215                 220                 


Tyr Lys Ala Gln Pro Val Ile Glu Phe Val Cys Glu Val Leu Asp Phe 
225                 230                 235                 240 


Lys Ser Ile Glu Glu Gln Gln Lys Pro Leu Thr Asp Ser Gln Arg Val 
                245                 250                 255     


Lys Phe Thr Lys Glu Ile Lys Gly Leu Lys Val Glu Ile Thr His Cys 
            260                 265                 270         


Gly Gln Met Lys Arg Lys Tyr Arg Val Cys Asn Val Thr Arg Arg Pro 
        275                 280                 285             


Ala Ser His Gln Thr Phe Pro Leu Gln Gln Glu Ser Gly Gln Thr Val 
    290                 295                 300                 


Glu Cys Thr Val Ala Gln Tyr Phe Lys Asp Arg His Lys Leu Val Leu 
305                 310                 315                 320 


Arg Tyr Pro His Leu Pro Cys Leu Gln Val Gly Gln Glu Gln Lys His 
                325                 330                 335     


Thr Tyr Leu Pro Leu Glu Val Cys Asn Ile Val Ala Gly Gln Arg Cys 
            340                 345                 350         


Ile Lys Lys Leu Thr Asp Asn Gln Thr Ser Thr Met Ile Arg Ala Thr 
        355                 360                 365             


Ala Arg Ser Ala Pro Asp Arg Gln Glu Glu Ile Ser Lys Leu Met Arg 
    370                 375                 380                 


Ser Ala Ser Phe Asn Thr Asp Pro Tyr Val Arg Glu Phe Gly Ile Met 
385                 390                 395                 400 


Val Lys Asp Glu Met Thr Asp Val Thr Gly Arg Val Leu Gln Pro Pro 
                405                 410                 415     


Ser Ile Leu Tyr Gly Gly Arg Asn Lys Ala Ile Ala Thr Pro Val Gln 
            420                 425                 430         


Gly Val Trp Asp Met Arg Asn Lys Gln Phe His Thr Gly Ile Glu Ile 
        435                 440                 445             


Lys Val Trp Ala Ile Ala Cys Phe Ala Pro Gln Arg Gln Cys Thr Glu 
    450                 455                 460                 


Val His Leu Lys Ser Phe Thr Glu Gln Leu Arg Lys Ile Ser Arg Asp 
465                 470                 475                 480 


Ala Gly Met Pro Ile Gln Gly Gln Pro Cys Phe Cys Lys Tyr Ala Gln 
                485                 490                 495     


Gly Ala Asp Ser Val Glu Pro Met Phe Arg His Leu Lys Asn Thr Tyr 
            500                 505                 510         


Ala Gly Leu Gln Leu Val Val Val Ile Leu Pro Gly Lys Thr Pro Val 
        515                 520                 525             


Tyr Ala Glu Val Lys Arg Val Gly Asp Thr Val Leu Gly Met Ala Thr 
    530                 535                 540                 


Gln Cys Val Gln Met Lys Asn Val Gln Arg Thr Thr Pro Gln Thr Leu 
545                 550                 555                 560 


Ser Asn Leu Cys Leu Lys Ile Asn Val Lys Leu Gly Gly Val Asn Asn 
                565                 570                 575     


Ile Leu Leu Pro Gln Gly Arg Pro Pro Val Phe Gln Gln Pro Val Ile 
            580                 585                 590         


Phe Leu Gly Ala Asp Val Thr His Pro Pro Ala Gly Asp Gly Lys Lys 
        595                 600                 605             


Pro Ser Ile Ala Ala Val Val Gly Ser Met Asp Ala His Pro Asn Arg 
    610                 615                 620                 


Tyr Cys Ala Thr Val Arg Val Gln Gln His Arg Gln Glu Ile Ile Gln 
625                 630                 635                 640 


Asp Leu Ala Ala Met Val Arg Glu Leu Leu Ile Gln Phe Tyr Lys Ser 
                645                 650                 655     


Thr Arg Phe Lys Pro Thr Arg Ile Ile Phe Tyr Arg Asp Gly Val Ser 
            660                 665                 670         


Glu Gly Gln Phe Gln Gln Val Leu His His Glu Leu Leu Ala Ile Arg 
        675                 680                 685             


Glu Ala Cys Ile Lys Leu Glu Lys Asp Tyr Gln Pro Gly Ile Thr Phe 
    690                 695                 700                 


Ile Val Val Gln Lys Arg His His Thr Arg Leu Phe Cys Thr Asp Lys 
705                 710                 715                 720 


Asn Glu Arg Val Gly Lys Ser Gly Asn Ile Pro Ala Gly Thr Thr Val 
                725                 730                 735     


Asp Thr Lys Ile Thr His Pro Thr Glu Phe Asp Phe Tyr Leu Cys Ser 
            740                 745                 750         


His Ala Gly Ile Gln Gly Thr Ser Arg Pro Ser His Tyr His Val Leu 
        755                 760                 765             


Trp Asp Asp Asn Arg Phe Ser Ser Asp Glu Leu Gln Ile Leu Thr Tyr 
    770                 775                 780                 


Gln Leu Cys His Thr Tyr Val Arg Cys Thr Arg Ser Val Ser Ile Pro 
785                 790                 795                 800 


Ala Pro Ala Tyr Tyr Ala His Leu Val Ala Phe Arg Ala Arg Tyr His 
                805                 810                 815     


Leu Val Asp Lys Glu His Asp Ser Ala Glu Gly Ser His Thr Ser Gly 
            820                 825                 830         


Gln Ser Asn Gly Arg Asp His Gln Ala Leu Ala Lys Ala Val Gln Val 
        835                 840                 845             


His Gln Asp Thr Leu Arg Thr Met Tyr Phe Ala 
    850                 855                 


<210>  112
<211>  18
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  RNA oligo having 6-carboxyfluorescein attached to its 3' end

<400>  112
gaucugagcc ugggagcu                                                     18


<210>  113
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DNA oligo having Dabcyl attached to its 5' end

<400>  113
agctcccagg ctcagatc                                                     18


<210>  114
<211>  184
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CPP-RNase fusion protein construct

<400>  114

Leu Asp Met Glu Asp Asn Asp Ile Ile Glu Ala His Arg Glu Gln Ile 
1               5                   10                  15      


Gly Leu Leu Leu Leu Arg Arg Arg Arg Arg Arg Arg Arg Arg Gly Gly 
            20                  25                  30          


Gly Gly Ser Met Tyr Gln Leu Glu Lys Glu Pro Ile Val Gly Ala Glu 
        35                  40                  45              


Thr Phe Tyr Val Asp Gly Ala Ala Asn Arg Glu Thr Lys Leu Gly Lys 
    50                  55                  60                  


Ala Gly Tyr Val Thr Asn Arg Gly Arg Gln Lys Val Val Thr Leu Thr 
65                  70                  75                  80  


Asp Thr Thr Asn Gln Lys Thr Glu Leu Gln Ala Ile Tyr Leu Ala Leu 
                85                  90                  95      


Gln Asp Ser Gly Leu Glu Val Asn Ile Val Thr Asp Ser Gln Tyr Ala 
            100                 105                 110         


Leu Gln Gly Ile Thr Gln Trp Ile His Asn Trp Lys Lys Arg Gly Trp 
        115                 120                 125             


Lys Thr Ala Asp Lys Lys Pro Val Lys Asn Val Asp Leu Val Asn Gln 
    130                 135                 140                 


Ile Ile Glu Gln Leu Ile Lys Lys Glu Lys Val Tyr Leu Ala Trp Val 
145                 150                 155                 160 


Pro Ala His Lys Gly Ile Gly Gly Asn Glu Gln Val Asp Lys Leu Val 
                165                 170                 175     


Ser Ala Gly Ile Arg Lys Val Leu 
            180                 


<210>  115
<211>  567
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CPP-RNase fusion nucleic acid construct

<400>  115
cctgaggatc tggacatgga agacaatgac attatcgaag ctcatcgtga acagattggt       60

ggtctgctgc tgctgcgtcg ccgtcgccgt cgccgccgtc gcggcggtgg cggtagcatg      120

taccagctgg agaaagaacc gatcgtgggc gcggaaacct tctacgttga tggcgccgcc      180

aaccgcgaaa ccaaactggg caaagccggc tacgttacga accgcggtcg ccagaaggtt      240

gtgacgctga cggataccac gaaccagaaa accgaactgc aagccatcta tctggcgctg      300

caagatagcg gtctggaagt gaacatcgtg accgatagcc agtacgcgct gcaaggcatc      360

acgcagtgga ttcacaactg gaagaaacgc ggctggaaga ccgcggacaa aaaaccggtg      420

aagaacgtgg atctggtgaa tcagatcatc gagcagctga tcaagaagga gaaggtgtat      480

ctggcgtggg tgccggcgca taaaggtatt ggcggcaacg aacaagttga caaactggtg      540

agcgcgggta ttcgcaaagt tctgtaa                                          567


<210>  116
<211>  167
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CPP-RNase fusion protein

<400>  116

Leu Leu Leu Leu Arg Arg Arg Arg Arg Arg Arg Arg Arg Gly Gly Gly 
1               5                   10                  15      


Gly Ser Met Tyr Gln Leu Glu Lys Glu Pro Ile Val Gly Ala Glu Thr 
            20                  25                  30          


Phe Tyr Val Asp Gly Ala Ala Asn Arg Glu Thr Lys Leu Gly Lys Ala 
        35                  40                  45              


Gly Tyr Val Thr Asn Arg Gly Arg Gln Lys Val Val Thr Leu Thr Asp 
    50                  55                  60                  


Thr Thr Asn Gln Lys Thr Glu Leu Gln Ala Ile Tyr Leu Ala Leu Gln 
65                  70                  75                  80  


Asp Ser Gly Leu Glu Val Asn Ile Val Thr Asp Ser Gln Tyr Ala Leu 
                85                  90                  95      


Gln Gly Ile Thr Gln Trp Ile His Asn Trp Lys Lys Arg Gly Trp Lys 
            100                 105                 110         


Thr Ala Asp Lys Lys Pro Val Lys Asn Val Asp Leu Val Asn Gln Ile 
        115                 120                 125             


Ile Glu Gln Leu Ile Lys Lys Glu Lys Val Tyr Leu Ala Trp Val Pro 
    130                 135                 140                 


Ala His Lys Gly Ile Gly Gly Asn Glu Gln Val Asp Lys Leu Val Ser 
145                 150                 155                 160 


Ala Gly Ile Arg Lys Val Leu 
                165         


<210>  117
<211>  229
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 RBP-CPP-RNase fusion protein construct

<400>  117

Leu Asp Met Glu Asp Asn Asp Ile Ile Glu Ala His Arg Glu Gln Ile 
1               5                   10                  15      


Gly Gly Gly Asp Tyr Ser His Cys Ser Pro Leu Arg Tyr Tyr Pro Trp 
            20                  25                  30          


Trp Lys Cys Thr Tyr Pro Asp Pro Gly Gly Gly Gly Ser Gly Gly Gly 
        35                  40                  45              


Gly Ser Gly Gly Gly Gly Ser Leu Leu Leu Leu Arg Arg Arg Arg Arg 
    50                  55                  60                  


Arg Arg Arg Arg Ala Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Ala 
65                  70                  75                  80  


Met Tyr Gln Leu Glu Lys Glu Pro Ile Val Gly Ala Glu Thr Phe Tyr 
                85                  90                  95      


Val Asp Gly Ala Ala Asn Arg Glu Thr Lys Leu Gly Lys Ala Gly Tyr 
            100                 105                 110         


Val Thr Asn Arg Gly Arg Gln Lys Val Val Thr Leu Thr Asp Thr Thr 
        115                 120                 125             


Asn Gln Lys Thr Glu Leu Gln Ala Ile Tyr Leu Ala Leu Gln Asp Ser 
    130                 135                 140                 


Gly Leu Glu Val Asn Ile Val Thr Asp Ser Gln Tyr Ala Leu Gln Gly 
145                 150                 155                 160 


Ile Thr Gln Trp Ile His Asn Trp Lys Lys Arg Gly Trp Lys Thr Ala 
                165                 170                 175     


Asp Lys Lys Pro Val Lys Asn Val Asp Leu Val Asn Gln Ile Ile Glu 
            180                 185                 190         


Gln Leu Ile Lys Lys Glu Lys Val Tyr Leu Ala Trp Val Pro Ala His 
        195                 200                 205             


Lys Gly Ile Gly Gly Asn Glu Gln Val Asp Lys Leu Val Ser Ala Gly 
    210                 215                 220                 


Ile Arg Lys Val Leu 
225                 


<210>  118
<211>  702
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  ACE2 RBP-CPP-RNase fusion nucleic acid construct

<400>  118
cctgaggatc tggacatgga agacaatgac attatcgaag ctcatcgtga acagattggt       60

ggtggcgatt atagccattg cagcccgctg cgctattatc cgtggtggaa atgcacctat      120

ccggatccgg gcggtggcgg cggtggcggc ggcagcggtg gcggcggcag cctgctgctg      180

ctgcgtcgcc gtcgccgtcg ccgccgtcgc gcggaagccg cggccaaaga agcggccgcg      240

aaagcgatgt accagctgga gaaagaaccg atcgtgggcg cggaaacctt ctacgttgat      300

ggcgccgcca accgcgaaac caaactgggc aaagccggct acgttacgaa ccgcggtcgc      360

cagaaggttg tgacgctgac ggataccacg aaccagaaaa ccgaactgca agccatctat      420

ctggcgctgc aagatagcgg tctggaagtg aacatcgtga ccgatagcca gtacgcgctg      480

caaggcatca cgcagtggat ccacaactgg aagaaacgcg gctggaagac cgcggacaaa      540

aaaccggtga agaacgtgga tctggtgaat cagatcatcg agcagctgat caagaaggag      600

aaggtgtatc tggcgtgggt gccggcgcat aaaggtattg gcggcaacga acaagttgac      660

aaactggtga gcgcgggtat tcgcaaagtt ctgtaactcg ag                         702


<210>  119
<211>  212
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 RBP-CPP-RNase fusion protein

<400>  119

Gly Asp Tyr Ser His Cys Ser Pro Leu Arg Tyr Tyr Pro Trp Trp Lys 
1               5                   10                  15      


Cys Thr Tyr Pro Asp Pro Glu Gly Gly Gly Gly Ser Gly Gly Gly Gly 
            20                  25                  30          


Ser Gly Gly Gly Gly Ser Leu Leu Leu Leu Arg Arg Arg Arg Arg Arg 
        35                  40                  45              


Arg Arg Arg Ala Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Ala Met 
    50                  55                  60                  


Tyr Gln Leu Glu Lys Glu Pro Ile Val Gly Ala Glu Thr Phe Tyr Val 
65                  70                  75                  80  


Asp Gly Ala Ala Asn Arg Glu Thr Lys Leu Gly Lys Ala Gly Tyr Val 
                85                  90                  95      


Thr Asn Arg Gly Arg Gln Lys Val Val Thr Leu Thr Asp Thr Thr Asn 
            100                 105                 110         


Gln Lys Thr Glu Leu Gln Ala Ile Tyr Leu Ala Leu Gln Asp Ser Gly 
        115                 120                 125             


Leu Glu Val Asn Ile Val Thr Asp Ser Gln Tyr Ala Leu Gln Gly Ile 
    130                 135                 140                 


Thr Gln Trp Ile His Asn Trp Lys Lys Arg Gly Trp Lys Thr Ala Asp 
145                 150                 155                 160 


Lys Lys Pro Val Lys Asn Val Asp Leu Val Asn Gln Ile Ile Glu Gln 
                165                 170                 175     


Leu Ile Lys Lys Glu Lys Val Tyr Leu Ala Trp Val Pro Ala His Lys 
            180                 185                 190         


Gly Ile Gly Gly Asn Glu Gln Val Asp Lys Leu Val Ser Ala Gly Ile 
        195                 200                 205             


Arg Lys Val Leu 
    210         


